Emerge Australia's InfoLine

Emerge Australia offers a free, national InfoLine service for the ME/CFS community, including our members, anyone living with ME/CFS, their carers and healthcare practitioners.

The InfoLine is available during business hours Monday to Friday, for the ME/CFS community to ask questions, seek information and connect with us.

Common queries include:

information about ME/CFS
support group information (in-person and online) around Australia
telehealth nurse service information and bookings
general advice
membership information
GP Education promotion materials
financial literacy resources for NDIS or DSP applications
donations

Get in touch with our helpful team today to connect, learn more and share your experience. If we are unable to answer your question or provide support, we will make a referral to a service who can.

You can contact the InfoLine on 1800 865 321 or email us - send emails to [email protected]

Contacting Emerge Australia

Please contact Emerge Australia on 03 9529 1344 or email us [email protected] for all other general enquiries including:

media and speaking requests
partnership opportunities
fundraising proposals
bequests
research collaborations
events and conferences

Latest

Help us give the gift of knowledge this Christmas

People with ME/CFS face multiple challenges every day. Despite the devastating impact of this illness, thousands of Australians living with ME/CFS struggle to access high-quality, knowledgeable help.
Research Digest 11/12/20

Welcome to the 61st edition of the Research Digest. This fortnight's edition features a study investigating microRNA expression differences in ME/CFS patients before and after experiencing PEM, and a study that aimed to develop a sensor-based method to track upright activity as a way to measure ME/CFS disease severity.
Research Digest 27/11/20

Welcome to the 60th edition of the Research Digest featuring a study that aimed to determine whether there are differences in cardiac function in ME/CFS patients and a plasma proteomic analysis study.
New ME/CFS Clinical Guidelines for the UK

The UK’s National Institute for Health and Care Excellence has published its long-awaited draft of the new ME/CFS clinical guidelines.

Open Medicine Foundation Australia

Emerge Australia is proud to be launching the 5th addition to a global network of OMF-established Collaborative Research Centres, with our partner, Open Medicine Foundation, seeing an Australian centre join with those at Harvard, Stanford, Uppsala, and Montreal universities.
Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.
Australian Research Centre to Open Early in 2021

The new Australian ME/CFS Centre for Collaborative Research is expected to officially open early in 2021
Research Digest 30/10/20

Welcome to the 58th edition of the Research Digest featuring a focus group study that aimed to gain insight into the PEM experiences of ME/CFS patients and a cluster analysis study defining subgroups of patients based on several measures of autonomic dysfunction.
Research Digest 04/09/20

Welcome to the 54th edition of the Research Digest. This fortnight's edition includes summary of a functional MRI study exploring brain responses to autonomic challenges in ME/CFS patients with and without temporomandibular disorder.
Research Digest 13/11/20

Welcome to the 59th edition of the Research Digest. This issue features a review article on the eitology of ME/CFS and a systematic review of neuroimaging studies.
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
Research Digest 16/10/20

Welcome to the 57th edition of the Research Digest featuring the results of the NHMRC ME/CFS Targeted Call for Research funding and a study that aimed to compare the subjective severity scoring of the SF-36 (based on the physical activity subscale) to two objective measures of activity in order to validate the way in which clinical severity is graded in ME/CFS.
What is fibromyalgia?

Fibromyalgia is an associated condition of ME/CFS
Accessibility